Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tinsay A Woreta

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2020
Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for ConcernTinsay A Woreta, Naga Chalasani
The Medical Clinics of North America|November 26, 2013
Evaluation of abnormal liver testsTinsay A Woreta, Saleh A Alqahtani
ACG Case Reports Journal|February 6, 2023
It Can't Be a Coincidence: A Comparison of Cases of Autoimmune Hepatitis After Vaccination Against COVID-19Julia R Gips, Tinsay A Woreta
Journal of Clinical and Translational Hepatology|July 12, 2019
A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North AmericaPeng-Sheng Ting, Anant Agarwalla, Tinsay A Woreta
World Journal of Clinical Cases|January 29, 2026
Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case reportArunkumar Krishnan, Kaleb Lucas, Laura Maas, et al.
The American Journal of Medicine|March 3, 2010
Exotic origin, familiar culpritTinsay A Woreta, Leonard S Feldman, Rosalyn W Stewart
World Journal of Clinical Cases|January 29, 2021
COVID-19: An overview and a clinical updateArunkumar Krishnan, James P Hamilton, Saleh A Alqahtani, et al.
Internal and Emergency Medicine|January 16, 2021
A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestationsArunkumar Krishnan, James P Hamilton, Saleh A Alqahtani, et al.
Journal of Diabetes|April 27, 2025
Adverse Liver and Renal Outcomes After Initiating SGLT-2i and GLP-1RA Therapy Among Patients With Diabetes and MASLDArunkumar Krishnan, Carolin V Schneider, Diptasree Mukherjee, et al.
AIDS (London, England)|March 17, 2023
Risk of adverse cardiovascular outcomes among people with HIV and nonalcoholic fatty liver diseaseArunkumar Krishnan, Omar T Sims, Phani Keerthi Surapaneni, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2020
Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for ConcernTinsay A Woreta, Naga Chalasani
The Medical Clinics of North America|November 26, 2013
Evaluation of abnormal liver testsTinsay A Woreta, Saleh A Alqahtani
ACG Case Reports Journal|February 6, 2023
It Can't Be a Coincidence: A Comparison of Cases of Autoimmune Hepatitis After Vaccination Against COVID-19Julia R Gips, Tinsay A Woreta
Journal of Clinical and Translational Hepatology|July 12, 2019
A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North AmericaPeng-Sheng Ting, Anant Agarwalla, Tinsay A Woreta
World Journal of Clinical Cases|January 29, 2026
Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case reportArunkumar Krishnan, Kaleb Lucas, Laura Maas, et al.
The American Journal of Medicine|March 3, 2010
Exotic origin, familiar culpritTinsay A Woreta, Leonard S Feldman, Rosalyn W Stewart
World Journal of Clinical Cases|January 29, 2021
COVID-19: An overview and a clinical updateArunkumar Krishnan, James P Hamilton, Saleh A Alqahtani, et al.
Internal and Emergency Medicine|January 16, 2021
A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestationsArunkumar Krishnan, James P Hamilton, Saleh A Alqahtani, et al.
Journal of Diabetes|April 27, 2025
Adverse Liver and Renal Outcomes After Initiating SGLT-2i and GLP-1RA Therapy Among Patients With Diabetes and MASLDArunkumar Krishnan, Carolin V Schneider, Diptasree Mukherjee, et al.
AIDS (London, England)|March 17, 2023
Risk of adverse cardiovascular outcomes among people with HIV and nonalcoholic fatty liver diseaseArunkumar Krishnan, Omar T Sims, Phani Keerthi Surapaneni, et al.
Pageof 3